Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CholestaGel enters phase III testing

Dec. 19, 1997

RSD-992: a novel 5-HT antagonist with erectogenic activity

Dec. 19, 1997

FDA approves Nutropin for GH deficiency in adults

Dec. 18, 1997

Several series of integrin antagonists prepared at Searle

Dec. 18, 1997

Antidiabetic agents under development at Takeda

Dec. 18, 1997

Plant-based estrogen prevents osteoporosis safely and effectively

Dec. 18, 1997

Clinical progress for Kirin's calcimimetic compound reported

Dec. 18, 1997

Antidiabetic drug research at Takeda

Dec. 17, 1997

FA-70D: a new cathepsin inhibitor from Taiho

Dec. 17, 1997

Vitamin D analogue undergoes phase I evaluation for osteoporosis

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...